Loading...

AIQ Solutions has contributed to a poster presentation at the 2019 ASCO Annual Meeting in Chicago, IL May 31-June 4 2019. This presentation is the result of a clinical study using AIQ's QTBI technology to assess of heterogeneity of response in patients using Enzalutamide.

This document contains claims that have not been reviewed by the FDA.  For information about applications in commercial distribution for patient management, see www.aiq-solutions.com/customers/hospitals